Neoplasms, Ovarian Completed Phase 2 Trials for Olaratumab (DB06043)

Also known as: Ovarian neoplasm / Ovarian Neoplasms / Neoplasms,Ovarian / Ovarian neoplasia / Ovarian tumor / Ovarian neoplasm NOS

IndicationStatusPhase
DBCOND0030336 (Neoplasms, Ovarian)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00913835A Study of Liposomal Doxorubicin With or Without IMC-3G3 in Platinum-refractory or Resistant Advanced Ovarian CancerTreatment